Dextroamphetamine
Sponsors
National Institute on Drug Abuse (NIDA), The University of Texas Health Science Center, Houston, Stony Brook University, Sunnybrook Health Sciences Centre, New York State Psychiatric Institute
Conditions
AOD Effects and ConsequencesAlzheimer DiseaseAttention Deficit Disorder With HyperactivityAttention Deficit Hyperactivity DisorderCocaine-Related DisordersConduct DisorderDementiaHealthy Adults
Phase 1
Phase 2
Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
CompletedNCT00000304
Start: 1997-08-31End: 2001-08-31Updated: 2017-01-12
Dextroamphetamine-Cocaine Behavioral Intervention - 5
CompletedNCT00000308
Start: 1995-09-30End: 2000-09-30Updated: 2017-01-12
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
CompletedNCT00000306
Start: 1994-09-30End: 2001-09-30Target: 140Updated: 2017-01-12
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
CompletedNCT00630682
Start: 2006-09-30End: 2011-08-31Updated: 2013-06-03
Studying Amphetamine Withdrawal in Humans
CompletedNCT01215929
Start: 2009-10-31End: 2014-05-31Updated: 2014-08-04
Amphetamine-Enhanced Stroke Recovery
CompletedNCT01905371
Start: 2001-04-30End: 2007-06-30Updated: 2013-07-23
Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
CompletedNCT02634684
Start: 2014-07-01End: 2020-08-31Updated: 2021-08-17
Phase 4
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
CompletedNCT00228046
Start: 2004-01-31End: 2007-07-31Target: 40Updated: 2013-10-31
Apathy Associated With Alzheimer's Disease
CompletedNCT00254033
Start: 2003-10-31End: 2006-10-31Target: 40Updated: 2017-04-28
Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
TerminatedNCT00296686
Start: 2001-09-30End: 2006-08-31Updated: 2012-04-27
Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD
CompletedNCT01220440
Start: 2006-01-31End: 2008-12-31Updated: 2010-10-14
Unknown Phase
Spectroscopic Imaging at 4T: A Drug Challenge Study
TerminatedNCT01577706
Start: 2013-06-30End: 2013-12-31Updated: 2017-04-04
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia
WithdrawnNCT03999190
Start: 2019-07-31End: 2025-07-31Updated: 2020-05-29
A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
CompletedNCT04132557
Start: 2019-10-09End: 2019-10-25Updated: 2025-06-25